Kidney Renal Cancer Drugs Comprehensive Study by Type (Anti-angiogenesis therapy, Tyrosine kinase inhibitors (TKIs), MTOR inhibitors), Application (Clear cell renal cell carcinomas (ccRCC), Papillary renal cell carcinoma (PRCC), Chromophobe RCC, Collecting duct RCC, Unclassified RCC, Others), End-User (Hospitals, Cancer Therapy Centers, Home Care Settings) Players and Region - Global Market Outlook to 2030
Edition: Single User ;
If you have shopped with us before, please enter your details below. If you are a new customer, please proceed to the Billing section.
Lost your password?